Sofosbuvir–Velpatasvir Fixed Drug Combination for the Treatment of Chronic Hepatitis C Infection in Patients With End-Stage Renal Disease and Kidney Transplantation
ConclusionOur study showed excellent efficacy with the safety profile of this drug combination in end-stage renal disease patients. However, larger prospective studies and multicenter randomized controlled trials are needed for further confirmation.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
More News: Chronic Kidney Disease | Cirrhosis | Dialysis | Dyspepsia | Endoscopy | Gastroenterology | Hemodialysis | Hepatitis | Hepatitis B | Hepatitis C | India Health | Kidney Transplant | Kidney Transplantation | PET Scan | Study | Transplants | Urology & Nephrology | Virology